Oncologix Tech, Inc. announced a private placement of a promissory note for gross proceeds of $100,000 with a non-affiliated accredited Investor on July 26, 2013. The company issued an additional 2,500 series D convertible preferred stock in the transaction. The note carries a coupon of 18% per annum and would mature on January 26, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+190.94% | 7.13B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 820M | |
+1.72% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. announced that it has received $0.1 million in funding